盟科药业：股东计划合计减持不超6%公司股份

Core Viewpoint - Mengke Pharmaceutical (688373.SH) announced that shareholders BestIdea, JSR, and GPTMT plan to reduce their holdings by up to 39.34 million shares, representing no more than 6% of the company's total share capital, primarily due to personal funding needs [1] Summary by Relevant Categories Shareholder Actions - Shareholders BestIdea, JSR, and GPTMT intend to reduce their stakes in the company through centralized bidding and block trading [1] - The total number of shares to be reduced is up to 39.34 million [1] Company Capital Structure - The planned reduction accounts for a maximum of 6% of the company's total share capital [1]